Market Overview

US Stock Futures Signal Higher Start On Wall Street

US Stock Futures Signal Higher Start On Wall Street

Pre-open movers

US stock futures traded higher in early pre-market trade. Futures for the Dow Jones Industrial Average jumped 94 points to 17,743.00, while the Standard & Poor's 500 index futures rose 11.80 points to 2,047.10. Futures for the Nasdaq 100 index climbed 23.50 points to 4,224.25.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 1.30%, STOXX Europe 600 Index gaining 0.98% and German DAX 30 index gaining 1.57%. French CAC 40 Index jumped 1.54% and London's FTSE 100 Index rose 0.37%.

In Asian markets, Hong Kong's Hang Seng Index climbed 0.45%, China's Shanghai Composite Index slipped 1.71% and India's Sensex jumped 0.46%

Broker Recommendation
Analysts at JMP Securities downgraded Morgan Stanley (NYSE: MS) from Market Outperform to Market Perform and removed the price target of $38.00.

Morgan Stanley's shares closed at $36.88 on Friday.

Breaking news

  • QIAGEN NV (NASDAQ: QGEN) announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer. To read the full news, click here.
  • Foundation Medicine, Inc. (NASDAQ: FMI) and Roche (OTC: RHHBY) announced today that they will enter into a broad strategic collaboration to further advance Foundation Medicine's market-leading position in molecular information and genomic analysis while providing Roche a unique opportunity to optimize the identification and development of novel treatment options for cancer patients. To read the full news, click here.
  • Auspex Pharmaceuticals, Inc. (NASDAQ: ASPX) today announced favorable topline safety results from its thorough QT (TQT) clinical trial evaluating the effects of SD-809 on cardiac repolarization, based on placebo-corrected, time-matched changes from baseline in the corrected QT (QTc) interval. To read the full news, click here.
  • Shire PLC (NASDAQ: SHPG) has agreed to acquire NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) for $5.2 billion or $46 a share. To read the full news, click here.

Posted-In: JMP Securities US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (FMI + ASPX)

View Comments and Join the Discussion!

Nomura Upgrades Alcoa To Buy

UPDATE: Credit Suisse Lowers Price Target On WhiteWave Foods On Positive Share Price Outlook